2021 Q4 Form 10-Q Financial Statement

#000121390021056795 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $1.491M $1.487M $930.0K
YoY Change 60.3% 37.59% 38.81%
Cost Of Revenue $291.7K $355.0K $820.0K
YoY Change -64.43% 2.17% 110.26%
Gross Profit $1.199M $1.132M $110.0K
YoY Change 990.08% 54.37% -60.71%
Gross Profit Margin 80.43% 76.12% 11.83%
Selling, General & Admin $5.929M $4.647M $5.410M
YoY Change 9.6% 1.17% -25.58%
% of Gross Profit 494.47% 410.48% 4918.18%
Research & Development $741.7K $470.3K $1.020M
YoY Change -27.28% -25.23% -37.04%
% of Gross Profit 61.86% 41.54% 927.27%
Depreciation & Amortization $95.06K $95.11K $110.0K
YoY Change -13.58% -4.89% 10.0%
% of Gross Profit 7.93% 8.4% 100.0%
Operating Expenses $6.671M $5.117M $6.430M
YoY Change 3.75% -2.01% -27.67%
Operating Profit -$5.472M -$3.985M -$6.320M
YoY Change -13.42% -11.22% -26.6%
Interest Expense $2.190K $3.830K $0.00
YoY Change 7.16% -100.0%
% of Operating Profit
Other Income/Expense, Net -$990.00 $63.00 $0.00
YoY Change -97.13%
Pretax Income -$4.921M -$3.985M -$6.320M
YoY Change -22.13% -11.18% -25.47%
Income Tax $25.52K $8.705K $0.00
% Of Pretax Income
Net Earnings -$17.22M -$3.994M -$6.320M
YoY Change 172.44% -10.98% -25.65%
Net Earnings / Revenue -1154.96% -268.56% -679.57%
Basic Earnings Per Share $0.06
Diluted Earnings Per Share -$69.88K -$57.45K -$139.1K
COMMON SHARES
Basic Shares Outstanding 70.70M shares 69.39M shares 45.45M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.69M $39.00M $22.63M
YoY Change 53.3% 50.17% -5.95%
Cash & Equivalents $34.69M $38.00M $4.242M
Short-Term Investments $1.001M $18.39M
Other Short-Term Assets $1.054M $1.476M $1.300M
YoY Change -18.96% -13.16% 18.18%
Inventory $1.361M $1.082M $876.4K
Prepaid Expenses
Receivables $438.0K $329.8K $270.5K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $37.54M $41.88M $25.06M
YoY Change 49.78% 46.45% -5.54%
LONG-TERM ASSETS
Property, Plant & Equipment $147.0K $171.0K $244.0K
YoY Change -39.77% -36.08% -29.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $591.0K $4.975M $828.0K
YoY Change -28.62% 441.15% -26.87%
Total Long-Term Assets $5.292M $5.686M $6.454M
YoY Change -18.01% -32.9% -27.71%
TOTAL ASSETS
Total Short-Term Assets $37.54M $41.88M $25.06M
Total Long-Term Assets $5.292M $5.686M $6.454M
Total Assets $42.83M $47.57M $31.52M
YoY Change 35.9% 28.31% -11.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $938.0K $1.251M $2.079M
YoY Change -54.88% -38.35% -60.09%
Accrued Expenses $4.486M $4.430M $2.966M
YoY Change 51.26% 74.68% -11.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $500.0K
YoY Change -100.0% -100.0% 400.0%
Total Short-Term Liabilities $5.485M $5.739M $5.890M
YoY Change -6.88% -1.25% -35.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.100M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $699.5K $715.5K $900.0K
YoY Change -22.28% -28.45% -35.71%
Total Long-Term Liabilities $699.5K $715.5K $2.000M
YoY Change -65.03% -68.89% 42.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.485M $5.739M $5.890M
Total Long-Term Liabilities $699.5K $715.5K $2.000M
Total Liabilities $6.185M $6.454M $7.874M
YoY Change -21.45% -21.09% -25.47%
SHAREHOLDERS EQUITY
Retained Earnings -$124.2M -$119.3M -$107.0M
YoY Change 16.09% 18.47% 28.16%
Common Stock $160.8M $159.8M $130.3M
YoY Change 23.49% 353439.77% 20.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.65M $40.48M $23.01M
YoY Change
Total Liabilities & Shareholders Equity $42.83M $47.57M $31.52M
YoY Change 35.9% 28.31% -11.12%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$17.22M -$3.994M -$6.320M
YoY Change 172.44% -10.98% -25.65%
Depreciation, Depletion And Amortization $95.06K $95.11K $110.0K
YoY Change -13.58% -4.89% 10.0%
Cash From Operating Activities -$4.354M -$3.447M -$3.090M
YoY Change 40.91% -25.22% -66.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.000M $8.000M $3.710M
YoY Change -73.05% -144.03% -77.5%
Cash From Investing Activities $1.000M $8.000M $3.710M
YoY Change -73.05% -144.03% -77.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.070K 18.76M -140.0K
YoY Change -97.81% 58.62% -53.33%
NET CHANGE
Cash From Operating Activities -4.354M -3.447M -3.090M
Cash From Investing Activities 1.000M 8.000M 3.710M
Cash From Financing Activities -3.070K 18.76M -140.0K
Net Change In Cash -3.357M 23.32M 480.0K
YoY Change -799.41% -312.94% -93.21%
FREE CASH FLOW
Cash From Operating Activities -$4.354M -$3.447M -$3.090M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Small Business
EntitySmallBusiness
true
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Document Transition Report
DocumentTransitionReport
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
false
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2965702 USD
CY2021Q3 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
USD
CY2020Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
311354 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001560258
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45559765 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Entity File Number
EntityFileNumber
001-38538
dei Entity Registrant Name
EntityRegistrantName
electroCore, Inc.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3454976
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Forge Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 205
dei Entity Address City Or Town
EntityAddressCityOrTown
Rockaway
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07866
dei City Area Code
CityAreaCode
973
dei Local Phone Number
LocalPhoneNumber
290-0097
dei Trading Symbol
TradingSymbol
ECOR
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
70697680 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37995008 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4241937 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1001080 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
18386160 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
329778 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
270546 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
1082325 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
876436 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1476348 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1288588 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
41884539 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
25063667 USD
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
4349009 USD
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
4865181 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
171028 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
244047 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
539728 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
517257 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
828011 USD
CY2021Q3 us-gaap Assets
Assets
47570749 USD
CY2020Q4 us-gaap Assets
Assets
31518163 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1250534 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2078699 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4429843 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
58482 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
534547 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5738859 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5890302 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
885333 USD
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1097946 USD
CY2021Q3 us-gaap Liabilities
Liabilities
6454389 USD
CY2020Q4 us-gaap Liabilities
Liabilities
7873581 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
USD
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70442309 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70442309 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45559765 shares
CY2021Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
70442 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
45560 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
159796442 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
130205027 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119261417 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106990148 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-124717 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-251467 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
40480750 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23008972 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
635610 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
635610 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41116360 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23644582 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47570749 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31518163 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1487093 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1080841 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3960401 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2567567 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
355046 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
347504 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1093304 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
918605 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
1132047 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
733337 USD
us-gaap Gross Profit
GrossProfit
2867097 USD
us-gaap Gross Profit
GrossProfit
1648962 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
470275 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
629002 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1794146 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3182646 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4646815 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4592936 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15644324 USD
CY2021Q3 ecor Restructuring And Other Severance Related Charges
RestructuringAndOtherSeveranceRelatedCharges
USD
CY2020Q3 ecor Restructuring And Other Severance Related Charges
RestructuringAndOtherSeveranceRelatedCharges
USD
ecor Restructuring And Other Severance Related Charges
RestructuringAndOtherSeveranceRelatedCharges
USD
ecor Restructuring And Other Severance Related Charges
RestructuringAndOtherSeveranceRelatedCharges
464606 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5117090 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
5221938 USD
us-gaap Operating Expenses
OperatingExpenses
17438470 USD
us-gaap Operating Expenses
OperatingExpenses
20074243 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3985043 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4488601 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-14571373 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18425281 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1422214 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2021Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
3834 USD
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
5719 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
8493 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
80460 USD
CY2021Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3771 USD
CY2020Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3522 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7293 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
13350 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2197 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1423414 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
67110 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3984980 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13147959 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18358171 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8705 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-876690 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3993685 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4486404 USD
us-gaap Profit Loss
ProfitLoss
-12271269 USD
us-gaap Net Income Loss
NetIncomeLoss
-17187281 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69511498 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44030685 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55308381 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36847548 shares
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-3993685 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-4486404 USD
us-gaap Profit Loss
ProfitLoss
-12271269 USD
us-gaap Net Income Loss
NetIncomeLoss
-17187281 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22282 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-81602 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
124366 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-145617 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
27 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2210 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2384 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3443 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-22255 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-83812 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
126750 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-149060 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4015940 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4570216 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12144519 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17336341 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23644582 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5383832 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
144144 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6920350 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2021Q1 ecor Stock Issued During Period Value Settlement Of Accrued Bonus
StockIssuedDuringPeriodValueSettlementOfAccruedBonus
399997 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
942183 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26667424 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2893752 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2893752 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
4861 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
837973 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24616506 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3993685 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-22255 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18764882 USD
CY2021Q3 ecor Issuance Of Stock To Satisfy Legal Fee Obligation
IssuanceOfStockToSatisfyLegalFeeObligation
990475 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
760437 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41116360 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24897118 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7959349 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
51148 USD
CY2020Q1 ecor Equity Financing Commitment Fee
EquityFinancingCommitmentFee
USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
744865 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17733782 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-116396 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7831535 USD
CY2020Q2 ecor Equity Financing Commitment Fee
EquityFinancingCommitmentFee
USD
CY2020Q3 ecor Financing Fees
FinancingFees
23199 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
288589 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
742928 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28896026 USD
us-gaap Profit Loss
ProfitLoss
-12271269 USD
us-gaap Profit Loss
ProfitLoss
-17187281 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2540593 USD
CY2020Q2 ecor Financing Fees
FinancingFees
167299 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1002758 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21542852 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
286448 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4486404 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-83812 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11203661 USD
CY2020Q3 ecor Equity Financing Commitment Fee
EquityFinancingCommitmentFee
USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-141159 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-23422 USD
ecor Gains Loss On Extinguishment Of Debt
GainsLossOnExtinguishmentOfDebt
1422214 USD
ecor Gains Loss On Extinguishment Of Debt
GainsLossOnExtinguishmentOfDebt
USD
ecor Legal Expense Settled With Stock
LegalExpenseSettledWithStock
-9525 USD
ecor Legal Expense Settled With Stock
LegalExpenseSettledWithStock
156434 USD
ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
56151 USD
ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
273070 USD
us-gaap Inventory Write Down
InventoryWriteDown
39478 USD
us-gaap Inventory Write Down
InventoryWriteDown
USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14893 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
59232 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-320186 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-270805 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15922 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-703257 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-561248 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
171835 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1631839 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
324316 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1407813 USD
ecor Increase Decrease In Right Of Use Operating Leases
IncreaseDecreaseInRightOfUseOperatingLeases
78622 USD
ecor Increase Decrease In Right Of Use Operating Leases
IncreaseDecreaseInRightOfUseOperatingLeases
USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
33277 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-355274 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9273543 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16469736 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5082730 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
22166376 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
22300000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10500000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17217270 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11666376 USD
ecor Shares Issued Net Of Related Expenses
SharesIssuedNetOfRelatedExpenses
25685232 USD
ecor Shares Issued Net Of Related Expenses
SharesIssuedNetOfRelatedExpenses
17139563 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25685232 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18550087 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
124112 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-145312 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33753071 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9731337 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4241937 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13563791 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3832454 USD
ecor Proceeds From Sale Of State Net Operating Losses
ProceedsFromSaleOfStateNetOperatingLosses
1425935 USD
ecor Proceeds From Sale Of State Net Operating Losses
ProceedsFromSaleOfStateNetOperatingLosses
1170890 USD
us-gaap Interest Paid Net
InterestPaidNet
4649 USD
us-gaap Interest Paid Net
InterestPaidNet
9366 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38622 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3254 USD
us-gaap Stock Issued1
StockIssued1
399997 USD
us-gaap Stock Issued1
StockIssued1
USD
ecor Accounts Payable Paid Through Issuance Of Common Stock
AccountsPayablePaidThroughIssuanceOfCommonStock
1000000 USD
ecor Accounts Payable Paid Through Issuance Of Common Stock
AccountsPayablePaidThroughIssuanceOfCommonStock
1548702 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
422765 USD
CY2021Q3 us-gaap Cash
Cash
500000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div id="t_ft_TFYWK222V400000000000000000000b"> <table cellpadding="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> (c) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> Use of Estimates </span></p> </td> </tr> </tbody> </table> </div> </div> </div> <p style="margin: 6pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">The preparation of financial statements in conformity with U.S.</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of these condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowances for doubtful accounts, trade credits, rebates, co-payment assistance and sales returns, valuation of inventory</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">, stock compensation, and contingencies. </span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div id="t_ft_RBNCVNO2E800000000000000000000b"> <table cellpadding="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> (d) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-weight: bold; font-style: italic;"> Revision of Statement of Cash Flows Activity  </span></p> </td> </tr> </tbody> </table> </div> <p style="margin: 6pt 0in 0in; font-size: 12pt; font-family: 'Times New Roman', serif; line-height: 1.1;"><span style="font-size: 10pt; line-height: inherit;">In preparation of its financial statements for the quarter ended March 31, 2021, the Company realized that proceeds from its July 1, 2020 Commercial Insurance Premium Finance and Security Agreement should have been treated as a noncash activity instead of grossed up on the accompanying condensed consolidated statement of cash flows. Even though the amount was not considered material, the financial statements have been revised. As a result, cash used in operating and cash provided by financing activities for the nine months ended September 30, 2020, decreased by approximately $600,000.</span></p> <p style="margin: 6pt 0in 0in; font-size: 12pt; font-family: 'Times New Roman', serif; line-height: 1.1;"><span style="font-size: 10pt; line-height: inherit;"><br/></span></p> <div id="t_ft_TVXHMYJ7OW00000000000000000000b"> <table cellpadding="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> (e) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-weight: bold; font-style: italic;"> Reclassification of Statement of Cash Flows Activity  </span></p> </td> </tr> </tbody> </table> </div> <p style="margin: 6pt 0pt 0pt; font-size: 12pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-indent: 0pt;"><span style="font-size: 10pt; line-height: inherit;">Certain prior period amounts have been reclassified to conform to current period presentation. The reclassifications did not have an impact on net loss as previously reported.</span><br/></p>
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
600000 USD
ecor Incurred Loss
IncurredLoss
12300000 USD
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
25700000 USD
CY2021Q3 ecor Cashand Cash Equivalentsand Marketable Securities
CashandCashEquivalentsandMarketableSecurities
39000000.0 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1487093 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1080841 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3960401 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2567567 USD
CY2021Q3 ecor Maximum Amount Of Reduction In Monthly Co Payments Of Each Prescription
MaximumAmountOfReductionInMonthlyCoPaymentsOfEachPrescription
100 USD
CY2021Q3 ecor Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
37995008 USD
CY2021Q3 ecor Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
USD
CY2021Q3 ecor Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37995008 USD
CY2021Q3 ecor Cash And Cash Equivalents And Marketable Securities Amortized Cost Basis Current
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCostBasisCurrent
38996514 USD
CY2021Q3 ecor Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gains Before Tax Current
CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainsBeforeTaxCurrent
USD
CY2021Q3 ecor Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax Current
CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent
426 USD
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
38996088 USD
CY2020Q4 ecor Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
4241937 USD
CY2020Q4 ecor Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
USD
CY2020Q4 ecor Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4241937 USD
CY2020Q4 ecor Cash And Cash Equivalents And Marketable Securities Amortized Cost Basis Current
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCostBasisCurrent
22630907 USD
CY2020Q4 ecor Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gains Before Tax Current
CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainsBeforeTaxCurrent
USD
CY2020Q4 ecor Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax Current
CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent
2810 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
22628097 USD
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
37995008 USD
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
38996088 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4241937 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
22628097 USD
CY2021Q3 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
820227 USD
CY2020Q4 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
1008653 USD
CY2021Q3 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
4163251 USD
CY2020Q4 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
4304415 USD
CY2021Q3 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
447856 USD
CY2021Q3 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
5431334 USD
CY2020Q4 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
5741617 USD
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
4349009 USD
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
4865181 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
1082325 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
876436 USD
CY2021Q3 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
1100000 USD
CY2020Q4 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
700000 USD
CY2021Q3 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
3200000 USD
CY2020Q4 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
4200000 USD
CY2021Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
52351 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
139597 USD
CY2020Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
149731 USD
CY2021Q3 us-gaap Lease Deposit Liability
LeaseDepositLiability
320000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
539728 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
517257 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
58482 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
715530 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
885333 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
774012 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1419880 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2021Q3 us-gaap Shares Issued
SharesIssued
200000 shares
CY2021Q3 us-gaap Cash
Cash
398523 USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2021Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2020Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
39414 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
160486 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
163962 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
167524 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
704900 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1236286 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
462274 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
774012 USD
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
166050 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
270543 USD
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1400403 USD
CY2020Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
164832 USD
CY2021Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
425067 USD
CY2020Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
371033 USD
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1424878 USD
CY2021Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
873592 USD
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
548705 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
USD
CY2021Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
320000 USD
CY2020Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
696026 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
734416 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4429843 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2965702 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
873592 USD
us-gaap Interest Expense
InterestExpense
2646 USD
CY2021Q3 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
18.8 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6501571 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5639793 shares
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
216944000 USD
CY2021Q3 ecor Warrants And Rights Outstanding Expired
WarrantsAndRightsOutstandingExpired
498255 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3815585 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.56
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M24D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
342551 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
36000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1345136 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.97
ecor Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
21600 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
29458 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.22
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5131263 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.62
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
73800 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1988192 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.67
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
760437 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
742928 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2540593 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2490551 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5100000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.33
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.802 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.421 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q2 ecor Proceeds From Sale Of Net Operating Losses
ProceedsFromSaleOfNetOperatingLosses
1400000 USD
CY2021Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
880000000000 USD
CY2021Q3 us-gaap Income Tax Refunds Discontinued Operations
IncomeTaxRefundsDiscontinuedOperations
549000 USD
CY2020Q2 ecor Proceeds From Sale Of Net Operating Losses
ProceedsFromSaleOfNetOperatingLosses
1200000 USD
CY2020Q3 ecor Number Of Investors As Defendants
NumberOfInvestorsAsDefendants
2 pure

Files In Submission

Name View Source Status
0001213900-21-056795-index-headers.html Edgar Link pending
0001213900-21-056795-index.html Edgar Link pending
0001213900-21-056795.txt Edgar Link pending
0001213900-21-056795-xbrl.zip Edgar Link pending
ecor-20210930.htm Edgar Link pending
ecor-20210930.xsd Edgar Link pending
ecor-20210930_cal.xml Edgar Link unprocessable
ecor-20210930_def.xml Edgar Link unprocessable
ecor-20210930_htm.xml Edgar Link completed
ecor-20210930_lab.xml Edgar Link unprocessable
ecor-20210930_pre.xml Edgar Link unprocessable
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex321_3.htm Edgar Link pending
ex322_4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending